Optimization and validation of a flow cytometric method for immunophenotyping peripheral blood lymphocytes from cynomolgus monkeys (Macaca fascicularis)

BACKGROUND: Guidelines published by the Food and Drug Administration and Center for Human Medicinal Products describe the need to assess immunotoxic effects in nonclinical studies that evaluate drug toxicity, including the use of immunophenotyping to measure immunotoxicity. We are not aware of previous studies, however, that have validated methods for immunophenotyping peripheral blood lymphocyte subsets in whole blood samples from cynomolgus monkeys. OBJECTIVE: The purpose of this study was to optimize and validate a flow cytometric assay for immunophenotyping lymphocytes in the peripheral blood of cynomolgus monkeys. METHODS: A series of prevalidation experiments were done to determine optimal reagents, volumes, timing, and other procedural details of the flow cytometric assay. Using the optimized method, we then determined precision, interindividual variation, laboratory-to-laboratory variability, and sample stability. Stabilized human blood was used as a positive control for staining, processing, and analysis. The percentage and number of pan-T cells (CD3+), T-helper cells (CD3+4+), T cytotoxic/suppressor cells (CD3+8+), natural killer cells (CD3-16+), and B-cells (CD3-20+) were determined in 146 male and 140 female, clinically healthy monkeys and reference intervals were calculated. RESULTS: By doing 4-color staining with a lyse-wash method, intra- and interassay precision were <5% for all lymphocyte subsets. Variability between technicians and laboratories was minimal (CVs<3%). Samples were stable for up to 24 hours after staining and fixing. CONCLUSIONS: The validated method is extremely robust and can be performed under good laboratory practice conditions to support nonclinical studies. Reference intervals for lymphocyte subsets were similar to those previously reported.     

鸡粒细胞巨噬细胞集落刺激因子-猪干扰素α1融合基因在大肠埃希菌中的可溶性表达及其生物学活性研究

为可溶性表达重组鸡粒细胞巨噬细胞集落刺激因子(ChGM-CSF)与猪干扰素α1(PoIFNα1)融合蛋白,并研究其生物学活性,本研究分别提取鸡、猪肝脏细胞总RNA,采用RT-PCR方法扩增ChGM-CSF和PoIFNα1基因,经linker连接上述两种基因后将其克隆于pET-32a原核表达载体,转化E.coliBL21(DE3)菌株进行诱导表达,SDS-PAGE和western blot检测融合蛋白表达产物。在ST细胞/VSV病毒测定系统以细胞病变抑制法滴定该融合蛋白的抗病毒活性;同时用MTT法检测其对鸡淋巴细胞增殖活性的促进作用。结果显示,PCR扩增并融合后的ChGM-CSF和PoIFNα1融合基因约为1000bp,构建重组表达载体后,诱导表达的rChGM-CSF-PoIFNα1融合蛋白分子量约55ku,主要存在于破碎菌体的上清中,表达量较高。Westernblot检测结果显示,该融合蛋白分别能够与ChGM-CSF多抗和PoIFNα单克隆抗体特异性结合,其抗病毒比活性约为1.1×10^6IU/mg,并且具有促进鸡淋巴细胞增殖的活性。本研究为rChGM-CSF-PoIFNα1重组融合蛋白的研制及其相关活性的测定提供实验依据。     

硒对山羊子宫内膜淋巴细胞体外活化作用及对其分泌细胞因子的影响

分离妊娠山羊子宫内膜淋巴细胞(Endometrial lymphocyte,EML)后,分别加入4、8、12、16 mg/L的亚硒酸钠进行体外培养,探讨硒对EML的活化作用及其对分泌细胞因子IL-2I、L-4、TGFβ1及TGFβ2的影响。结果显示,8~16 mg/L的亚硒酸钠可显著地促进山羊EML的体外活化(P<0.01),并呈剂量依赖性。EML活化后,对IL-2的分泌呈微弱的促进作用;对IL-4、TGFβ1、TGFβ2的分泌有显著的促进作用。     

重组红火蚁毒素蛋白SoliⅣ致病机理的初步研究

作者通过研究重组红火蚁毒素蛋白Solenopsis invictaⅣ (SoliⅣ)对兔及外周血淋巴细胞的影响,探讨红火蚁毒素蛋白致病机制。通过分离兔外周血淋巴细胞进行培养,经不同浓度的重组红火蚁毒素蛋白SoliⅣ分别和细菌脂多糖(LPS)、刀豆蛋白(ConA)共同刺激后,MTT法测定淋巴细胞的增殖情况;体内试验：用重组蛋白SoliⅣ从兔背部皮下注入,观察兔的临床反应,定期采血,用ELISA方法测定兔血清中白介素 4（IL-4）和总IgE的变化。重组红火蚁毒素蛋白SoliⅣ浓度为25、50、75 μg/ml和LPS共刺激时,与单独LPS刺激对照组相比,淋巴细胞增殖活性显著增高（P<0.05）;浓度为15、25、50、75 μg/ml和ConA共刺激时,与单独ConA刺激对照组比较,淋巴细胞增殖活性显著增高（P<0.05）;重组SoliⅣ过敏兔的血清中IL-4和总IgE的水平升高,在20 h左右达到最高值。试验结果表明,一定浓度的重组红火蚁毒素蛋白SoliⅣ能引起体外培养的T、B淋巴细胞增殖,过敏体质兔在重组红火蚁毒素蛋白SoliⅣ刺激后能引起Ⅰ型变态反应。     

Prognostic significance of clinical presentation,induction and rescue treatment in 42 cases of canine centroblastic diffuse large B‐cell multicentric lymphoma in the United Kingdom

Canine lymphoma is a heterogeneous group of diseases and many previous studies have evaluated the response of a mixed population of lymphoma cases to one specific treatment protocol. The aim of this retrospective study was to describe the outcome and prognostic factors in 42 cases of multicentric centroblastic diffuse large B‐cell lymphoma treated with either a COP‐type (35%) or CHOP‐type (64%) induction chemotherapy. The objective response rate to induction therapy was 94%; entire dogs had a greater rate of complete vs partial remissions than neutered dogs (P = .017). Median progression‐free survival for the first remission (PFS1) was 182 days; absence of anaemia at diagnosis (P = .002) and pretreatment neutrophil:lymphocyte ratio (NLR) below 9.44 (P = .015) were independently predictive of longer PFS1. Fifty‐eight percent of dogs received rescue protocols with an objective response rate of 81%; 31% of dogs received further rescue protocols (up to a total of 5) and the median number of protocols administered were 2. Median overall survival (OS) was 322 days, the 1‐year survival rate was 38% and the 2‐year survival rate was 9%. Lymphocyte:monocyte ratio above 1.43 (P = .031), NLR below 11.44 (P = .009), the combination of induction and rescue therapy (P = .030) and the total number of doxorubicin doses used (P = .002) were independently predictive of longer OS. Use of a COP‐type protocol induction compared with CHOP did not undermine OS providing doxorubicin was used as rescue therapy.     

甘肃棘豆黄酮抗氧化活性及免疫活性的研究

为研究甘肃棘豆黄酮的抗氧化及免疫活性,试验通过1,1-二苯基-2-三硝基苯肼（DPPH）自由基、超氧阴离子自由基和羟基自由基的清除率测定其抗氧化活性,通过测定不同浓度甘肃棘豆黄酮对小鼠脾脏淋巴细胞增殖能力、白细胞介素2（IL-2）和免疫球蛋白G （IgG）抗体形成的影响研究其免疫活性。结果显示,甘肃棘豆黄酮对DPPH自由基清除率最高为32.23%,略高于维生素E （28.55%）,低于维生素C （97.05%）;对超氧阴离子自由基清除率最高为80.03%,高于维生素E （69.70%）,低于维生素C （98.69%）;对羟基自由基清除率最高为30.39%,低于维生素C （98.98%）、略低于维生素E （32.57%）。在小鼠脾脏淋巴细胞增殖试验中,随着甘肃棘豆黄酮溶液浓度的提高,脾脏淋巴细胞相对增殖率也提高,当其浓度为200 μg/mL时,小鼠脾脏淋巴细胞的增殖率为23.40%;200 μg/mL甘肃棘豆黄酮组IL-2水平极显著高于对照组（P<0.01）,50和100 μg/mL甘肃棘豆黄酮组与对照组无显著差异（P>0.05）;各甘肃棘豆黄酮组IgG抗体水平均极显著高于对照组（P<0.01）,其中,50 μg/mL甘肃棘豆黄酮组极显著高于100和200 μg/mL甘肃棘豆黄酮组（P<0.01）,100 μg/mL甘肃棘豆黄酮组极显著高于200 μg/mL甘肃棘豆黄酮组（P<0.01）。综上所述,甘肃棘豆黄酮具有较好的抗氧化活性及免疫活性。     

柱状嗜纤维菌脂多糖对鲤不同组织中离体培养淋巴细胞转化率的影响

从鲤胸腺,头肾和血液中分离淋巴细胞,在添加不同剂量的柱状嗜纤维菌脂多糖的ＲＭＰＩ－１６４０培养基中培养一定时间后,采用ＭＴＴ比色法测定ＬＰＳ对淋巴细胞的刺激指数,比较了ＬＰＳ对不同组织中离体培养淋巴细胞的转化率。结果表明,ＬＰＳ添加量和培养时间对淋巴细胞的转化率都有明显的影响,当ＬＰＳ添加量２０μｇ／ｍｌ,培养时间为７２ｈ,鲤各种组织淋巴细胞的转化率达到峰值.     

鱼类外周血淋巴细胞的分离技术

通过对分离草鱼（ Ｃｔｅｎｏｐｈａｒｙｎｇｏｄｏｎ ｉｄｅｌｌａ） 外周血淋巴细胞技术的探索,发现用相对体积质量为１ ．０８０ ～１ ．０８５ 的Ｆｉｃｏｌｌ－ Ｕｒｏｇｒａｆｉｎ 分层液可将草鱼外周血中淋巴细胞１００ ％ 地分离出来,这对进一步研究鱼类淋巴细胞的结构、功能具有重要意义。同时测得草鱼各类血细胞的相对体积质量：淋巴细胞为１ ．０７７ ±０ ．００２ ,粒细胞为１ ．０９６ ±０ ．００３ ,红细胞为１ ．１１１ ±０ ．００２ 。     

香菇多糖和黄芪多糖对马立克氏病强毒感染雏鸡白细胞介素2活性和淋巴细胞增殖反应的影响

１日龄ＡＡ肉用雏鸡以马立克氏病强毒（ｖＭＤＶ）人工感染后,马立克氏病（ＭＤ）发病率３３．７５％,死亡率１１．２５％。同健康雏鸡相比,ＩＬ－２诱生活性和Ｔ淋巴细胞增殖反应降低（Ｐ＞０．０５）和显著降低（Ｐ＜０．０５）。ｖＭＤＶ感染雏鸡注射香菇多糖和黄芪多糖,ＭＤ发病率分别为２０％、１７．５％,死亡率分别为７．５％、５％。同感染组相比,感染／香菇组和感染／黄芪组的ＩＬ－２诱生活性和Ｔ淋巴细胞增殖反应均升高（Ｐ＞０．０５）和显著升高（Ｐ＜０．０５）。